Bottom line
What is DRGVX's expense ratio?
DRGVX's expense ratio is 0.68%, or about $68 a year on every $10,000 invested. That is cheaper than 65% of large value funds we track (median 0.81%). It has no front-end sales load.
Updated Dec 23, 2025
DRGVX fee table
| Net expense ratio | 0.68% |
|---|---|
| Gross expense ratio | 0.71% |
| Management fee | 0.6% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 0.11% |
| Fee waiver / reimbursement | -0.03% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Dec 23, 2025
What DRGVX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| DRGVX | $69 | $224 | $392 | $880 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.68% expense ratio costs roughly $38,700 in lost growth, versus about $45,600 for the median large value fund (0.81%).